Linda Dirven

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 46

Top Venues

Neuro-oncology practice

Journal of neuro-oncology

Neuro-oncology advances

Neuro-oncology

Leiden University Medical Center

VU University Amsterdam (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leiden University Medical Center Jun 01 2015

Netherlands

Senior researcher / epidemiologist :: Neurology and Radiation Oncology

Education History

VU University Amsterdam

Netherlands

PHD :: Department of Rheumatology

London Metropolitan University

United Kingdom

MSC :: Department of Health and Human Sciences

VU University Amsterdam

Netherlands

MSC :: Faculty of Human Movement Sciences

VU University Amsterdam

Netherlands

BSC :: Faculty of Human Movement Sciences

Publications

Christopher Paul Millward, Abdurrahman I Islim, Terri S Armstrong, Heather Barrington, Sabrina Bell, Andrew R Brodbelt, Helen Bulbeck, Linda Dirven, Paul L Grundy, Mohsen Javadpour, Sumirat M Keshwara, Shelli D Koszdin, Anthony G Marson, Michael W McDermott, Torstein R Meling, Kathy Oliver, Puneet Plaha, Matthias Preusser, Thomas Santarius, Nisaharan Srikandarajah, Martin J B Taphoorn, Carole Turner, Colin Watts, Michael Weller, Paula R Williamson, Gelareh Zadeh, Amir H Zamanipoor Najafabadi, Michael D Jenkinson, null null
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review. Neuro-oncology advances 6 (1) (2024)
Daniëlle van Dorth, Feng Yan Jiang, Bárbara Schmitz-Abecassis, Robert J I Croese, Martin J B Taphoorn, Marion Smits, Johan A F Koekkoek, Linda Dirven, Jeroen de Bresser, Matthias J P van Osch
Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging. NMR in biomedicine 37 (9) (2024)
Florien W Boele, Lena Rosenlund, Sara Nordentoft, Sara Melhuish, Emma Nicklin, Isabelle Rydén, Aoife Williamson, Marike Donders-Kamphuis, Matthias Preusser, Emilie Le Rhun, Barbara Kiesel, Giuseppe Minniti, Julia Furtner, Linda Dirven, Martin J B Taphoorn, Norbert Galldiks, Roberta Rudà, Anthony J Chalmers, Susan C Short, Karin Piil
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives. Neuro-oncology practice 11 (4) (2024)
Christopher Paul Millward, Sumirat M Keshwara, Terri S Armstrong, Heather Barrington, Sabrina Bell, Andrew R Brodbelt, Helen Bulbeck, Linda Dirven, Paul L Grundy, Abdurrahman I Islim, Mohsen Javadpour, Shelli D Koszdin, Anthony G Marson, Michael W McDermott, Torstein R Meling, Kathy Oliver, Puneet Plaha, Matthias Preusser, Thomas Santarius, Nisaharan Srikandarajah, Martin J B Taphoorn, Carole Turner, Colin Watts, Michael Weller, Paula R Williamson, Gelareh Zadeh, Amir H Zamanipoor Najafabadi, Michael D Jenkinson, null null
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review. Neuro-oncology advances 6 (1) (2024)
Christopher Paul Millward, Abdurrahman I Islim, Terri S Armstrong, Heather Barrington, Sabrina Bell, Andrew R Brodbelt, Helen Bulbeck, Linda Dirven, Paul L Grundy, Mohsen Javadpour, Sumirat M Keshwara, Shelli D Koszdin, Anthony G Marson, Michael W McDermott, Torstein R Meling, Kathy Oliver, Puneet Plaha, Matthias Preusser, Thomas Santarius, Nisaharan Srikandarajah, Martin J B Taphoorn, Carole Turner, Colin Watts, Michael Weller, Paula R Williamson, Gelareh Zadeh, Amir H Zamanipoor Najafabadi, Michael D Jenkinson, null null
The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review. Neuro-oncology advances 6 (1) (2024)
Daniëlle van Dorth, Feng Yan Jiang, Bárbara Schmitz-Abecassis, Robert J I Croese, Martin J B Taphoorn, Marion Smits, Johan A F Koekkoek, Linda Dirven, Jeroen de Bresser, Matthias J P van Osch
Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging. NMR in biomedicine (2024)
Christopher Paul Millward, Sumirat M Keshwara, Terri S Armstrong, Heather Barrington, Sabrina Bell, Andrew R Brodbelt, Helen Bulbeck, Linda Dirven, Paul L Grundy, Abdurrahman I Islim, Mohsen Javadpour, Shelli D Koszdin, Anthony G Marson, Michael W McDermott, Torstein R Meling, Kathy Oliver, Puneet Plaha, Matthias Preusser, Thomas Santarius, Nisaharan Srikandarajah, Martin J B Taphoorn, Carole Turner, Colin Watts, Michael Weller, Paula R Williamson, Gelareh Zadeh, Amir H Zamanipoor Najafabadi, Michael D Jenkinson, null null
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review. Neuro-oncology advances 6 (1) (2024)
Florien W Boele, Lena Rosenlund, Sara Nordentoft, Sara Melhuish, Emma Nicklin, Isabelle Rydén, Aoife Williamson, Marike Donders-Kamphuis, Matthias Preusser, Emilie Le Rhun, Barbara Kiesel, Giuseppe Minniti, Julia Furtner, Linda Dirven, Martin J B Taphoorn, Norbert Galldiks, Roberta Rudà, Anthony J Chalmers, Susan C Short, Karin Piil
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives. Neuro-oncology practice 11 (4) (2024)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology (2023)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology (2023)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology 161 (2) (2023)
Emilie Le Rhun, Florien W Boele, Giuseppe Minniti, Norbert Galldiks, Martin J B Taphoorn, Karin Piil, Roberta Rudà, Simone P Niclou, Marjolein Geurts, Matthias Preusser, Michael Weller, Susan C Short, Linda Dirven
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative. Neuro-oncology practice 11 (1) (2023)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology (2023)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology 161 (2) (2023)
Ameeta Retzer, Elin Baddeley, Stephanie Sivell, Hannah Scott, Annmarie Nelson, Helen Bulbeck, Kathy Seddon, Robin Grant, Richard Adams, Colin Watts, Olalekan Lee Aiyegbusi, Pamela Kearns, Samantha Cruz Rivera, Linda Dirven, Melanie Calvert, Anthony Byrne
Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study. Neuro-oncology advances 5 (1) (2023)
Jacoline E C Bromberg, Samar Issa, Bronno van der Holt, Matthijs van der Meulen, Linda Dirven, Monique C Minnema, Tatjana Seute, Marc Durian, Gavin Cull, Marjolein W M van der Poel, Wendy Bernadina Catharina Stevens, Josee M Zijlstra, Dieta Brandsma, Marcel Nijland, Kylie D Mason, Aart Beeker, Martine C J Abrahamse-Testroote, Martin J Van Den Bent, Daphne de Jong, Jeanette K Doorduijn
Survival, Neurocognitive Function and Health-Related Quality of life outcomes after (R-)MBVP for PCNSL: Final Results of the HOVON 105 / ALLG NHL 24 Study. Neuro-oncology (2023)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology 161 (2) (2023)
Maarten M J Wijnenga, Sybren L N Maas, Vera van Dis, C Mircea S Tesileanu, Johan M Kros, Linda Dirven, Hans M Hazelbag, Hendrikus J Dubbink, Arnaud J P E Vincent, Pim J French, Martin J van den Bent
Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation. Neuro-oncology advances 5 (1) (2023)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology (2023)
Pim B van der Meer, Linda Dirven, Caroline Hertler, Florien W Boele, Albert Batalla, Tobias Walbert, Alasdair G Rooney, Johan A F Koekkoek
Depression and anxiety in glioma patients. Neuro-oncology practice 10 (4) (2023)
Kwong T Quach, Linda Dirven, Aliede M Vingerhoed, Jeroen de Bresser, Ruben Dammers, Eelke M Bos, Wouter A Moojen, Wilco C Peul, Martin J B Taphoorn, Amir H Z Najafabadi, Wouter R van Furth
The prevalence and severity of fatigue in meningioma patients and its association with patient-, tumor- and treatment-related factors. Neuro-oncology advances 5 (1) (2023)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Correction to: Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology (2023)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology 161 (2) (2023)
Emilie Le Rhun, Florien W Boele, Giuseppe Minniti, Norbert Galldiks, Martin J B Taphoorn, Karin Piil, Roberta Rudà, Simone P Niclou, Marjolein Geurts, Matthias Preusser, Michael Weller, Susan C Short, Linda Dirven
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative. Neuro-oncology practice 11 (1) (2023)
Kevin A Huynh, Eva C Coopmans, Amir H Z Najafabadi, Linda Dirven, Saskia M Peerdeman, Nienke R Biermasz, Marco J T Verstegen, Wouter R van Furth, null null
Correction to: Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of neuro-oncology (2023)
Bárbara Schmitz-Abecassis, Linda Dirven, Janey Jiang, Jasmin Annica Kuhn-Keller, Robert J I Croese, Daniëlle van Dorth, Rashid Ghaznawi, Ilse M J Kant, Martin J B Taphoorn, Matthias J P van Osch, Johan A F Koekkoek, Jeroen de Bresser
MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival. Neuro-oncology advances 5 (1) (2023)
Mark P van Opijnen, C Mircea S Tesileanu, Linda Dirven, Pim B van der Meer, Maarten M J Wijnenga, Arnaud J P E Vincent, Marike L D Broekman, Hendrikus J Dubbink, Johan M Kros, Sjoerd G van Duinen, Marion Smits, Pim J French, Martin J van den Bent, Martin J B Taphoorn, Johan A F Koekkoek
IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas. Neuro-oncology (2022)
Lara Fritz, Marthe C M Peeters, Hanneke Zwinkels, Johan A F Koekkoek, Jaap C Reijneveld, Maaike J Vos, H Roeline W Pasman, Linda Dirven, Martin J B Taphoorn
Advance care planning (ACP) in glioblastoma patients: Evaluation of a disease-specific ACP program and impact on outcomes. Neuro-oncology practice 9 (6) (2022)
Johan A F Koekkoek, Pim B van der Meer, Andrea Pace, Caroline Hertler, Rebecca Harrison, Heather E Leeper, Deborah A Forst, Rakesh Jalali, Kathy Oliver, Jennifer Philip, Martin J B Taphoorn, Linda Dirven, Tobias Walbert
Palliative care and end-of-life care in adults with malignant brain tumors. Neuro-oncology (2022)
Alan M George, Shubhi Gupta, Sumirat M Keshwara, Mohammad A Mustafa, Conor Scott Gillespie, George E Richardson, Amy C Steele, Amir H Z Najafabadi, Linda Dirven, Anthony G Marson, Abdurrahman I Islim, Michael D Jenkinson, Christopher Paul Millward
Meningioma systematic reviews and meta-analyses: an assessment of reporting and methodological quality. British journal of neurosurgery (2022)
Florien W Boele, Caroline Hertler, Linda Dirven, Karin Piil, Paula R Sherwood
Family caregiver constructs and outcome measures in neuro-oncology: A systematic review. Neuro-oncology practice 9 (6) (2022)
Fleur H J Kaptein, Milou A M Stals, Maaike Y Kapteijn, Suzanne C Cannegieter, Linda Dirven, Sjoerd G van Duinen, Ronald van Eijk, Menno V Huisman, Eva E Klaase, Martin J B Taphoorn, Henri H Versteeg, Jeroen T Buijs, Johan A F Koekkoek, Frederikus Albertus Klok
Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma. Journal of thrombosis and haemostasis : JTH 20 (7) (2022)
Linda Dirven
Importance of evaluating health-related quality of life issues in survivors of WHO grade II or III gliomas. Neuro-oncology practice 9 (1) (2022)
Johan A F Koekkoek, Pim B van der Meer, Martin J B Taphoorn, Linda Dirven
Letter regarding "SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors". Neuro-oncology 24 (3) (2022)
Quirien Oort, Linda Dirven, Sietske A M Sikkes, Neil Aaronson, Florien W Boele, Christine Brannan, Jonas Egeter, Robin Grant, Martin Klein, Irene M Lips, Yoshitaka Narita, Hitomi Sato, Monika Sztankay, Günther Stockhammer, Andrea Talacchi, Bernard M J Uitdehaag, Jaap C Reijneveld, Martin J B Taphoorn
Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL? Neuro-oncology practice 9 (4) (2022)
Christopher Paul Millward, Terri S Armstrong, Heather Barrington, Andrew R Brodbelt, Helen Bulbeck, Anthony Byrne, Linda Dirven, Carrol Gamble, Paul L Grundy, Abdurrahman I Islim, Mohsen Javadpour, Sumirat M Keshwara, Sandhya T Krishna, Conor L Mallucci, Anthony G Marson, Michael W McDermott, Torstein R Meling, Kathy Oliver, Barry Pizer, Puneet Plaha, Matthias Preusser, Thomas Santarius, Nisaharan Srikandarajah, Martin J B Taphoorn, Colin Watts, Michael Weller, Paula R Williamson, Gelareh Zadeh, Amir H Zamanipoor Najafabadi, Michael D Jenkinson
Opportunities and challenges for the development of "core outcome sets" in neuro-oncology. Neuro-oncology 24 (7) (2022)
Marijke B Coomans, Linda Dirven, Neil Aaronson, Brigitta G Baumert, Martin J Van Den Bent, Andrew Bottomley, Alba A Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmström, Francesca Martinelli, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C Reijneveld, Martin J B Taphoorn
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period. Neuro-oncology 24 (12) (2022)
Linda Dirven, Jammbe Z Musoro, Corneel Coens, Jaap C Reijneveld, Martin J B Taphoorn, Florien W Boele, Mogens Groenvold, Martin J van den Bent, Roger Stupp, Galina Velikova, Kim Cocks, Mirjam A G Sprangers, Madeleine T King, Hans-Henning Flechtner, Andrew Bottomley
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients. Neuro-oncology 23 (8) (2021)
Linda Dirven, Maartje E Vos, Tobias Walbert, Terri S Armstrong, David Arons, Martin J van den Bent, Jaishri Blakeley, Paul D Brown, Helen Bulbeck, Susan M Chang, Corneel Coens, Mark R Gilbert, Robin Grant, Rakesh Jalali, Danielle Leach, Heather Leeper, Tito R Mendoza, Lakshmi Nayak, Kathy Oliver, Jaap C Reijneveld, Emilie Le Rhun, Larry Rubinstein, Michael Weller, Patrick Y Wen, Martin J B Taphoorn
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative. Neuro-oncology practice 8 (4) (2021)
Marjolein E de Bruin, Pim B van der Meer, Linda Dirven, Martin J B Taphoorn, Johan A F Koekkoek
Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review. Neuro-oncology practice 8 (5) (2021)
Matthijs van der Meulen, Linda Dirven, Esther J J Habets, Katerina Bakunina, Marion Smits, Hakim C Achterberg, Tatjana Seute, Gavin Cull, Harry Schouten, Josée M Zijlstra, Dieta Brandsma, Roelien H Enting, Max Beijert, Martin J B Taphoorn, Martin J Van Den Bent, Samar Issa, Jeanette K Doorduijn, Jacoline E C Bromberg
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial. Neuro-oncology 23 (8) (2021)
Hanneke Zwinkels, Linda Dirven, Helen J Bulbeck, Robin Grant, Esther J J Habets, Johan A F Koekkoek, Ingela Oberg, Kathy Oliver, Andrea Pace, Alasdair G Rooney, Maaike J Vos, Martin J B Taphoorn
Identification of characteristics that determine behavioral and personality changes in adult glioma patients. Neuro-oncology practice 8 (5) (2021)
Pim B van der Meer, Linda Dirven, Martin J Van Den Bent, Matthias Preusser, Martin J B Taphoorn, Roberta Rudá, Johan A F Koekkoek
Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members. Neuro-oncology practice 9 (2) (2021)
Amir H Z Najafabadi, Pim B van der Meer, Florien W Boele, Martin J B Taphoorn, Martin Klein, Saskia M Peerdeman, Wouter R van Furth, Linda Dirven, null null
The long-term caregiver burden in World Health Organization grade I and II meningioma: It is not just the patient. Neuro-oncology advances 3 (1) (2020)
Marijke B Coomans, Linda Dirven, Neil K Aaronson, Brigitta G Baumert, Martin van den Bent, Andrew Bottomley, Alba A Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmström, Francesca Martinelli, Jeff A Sloan, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C Reijneveld, Martin J B Taphoorn
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling. Neuro-oncology advances 2 (1) (2020)
Quirien Oort, Martin J B Taphoorn, Sietske A M Sikkes, Bernard M J Uitdehaag, Jaap C Reijneveld, Linda Dirven
Evaluation of the content coverage of questionnaires containing basic and instrumental activities of daily living (ADL) used in adult patients with brain tumors. Journal of neuro-oncology 143 (1) (2019)

Linda Dirven.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Linda Dirven